Alemtuzumab

ATC L04AG06 · 10 markets · 21 records

Alemtuzumab 10 markets · 21 records Forms

AU 5 records · 4 strengths

  • 12 mg/1.2 mLinjectionLEMTRADA also in GB·US·SG
  • 30 mginjectionMABCAMPATH alemtuzumab 30mg/mL concentrate solution for infusion vial also in US unknown
  • 10 mg/mLinjectionLEMTRADA alemtuzumab 10 mg/mL injection concentrated vial unknown

Records without a stated strength · 1 LEMTRADA、MABCAMPATH

GB 3 records · 3 strengths

  • 12 mg/1.2 mLinjectionLemtrada 12mg/1.2ml concentrate for solution for infusion vials also in AU·US·SG
  • 30 mg/3 mLinjectionMabCampath 30mg/3ml concentrate for solution for infusion ampoules
  • 30 mg/1 mLinjectionMabCampath 30mg/1ml concentrate for solution for infusion vials

US 2 records · 2 strengths

  • 12 mg/1.2 mLinjectionLEMTRADA also in AU·GB·SG
  • 30 mginjectionCampath also in AU

CA 2 records · 2 strengths

SG 1 records · 1 strengths

ES 1 records · 1 strengths

MX 1 records · 1 strengths

    Records without a stated strength · 1 LEMTRADA

    TW 1 records · 1 strengths

    HK 1 records · 1 strengths

      Records without a stated strength · 1 LEMTRADA 12mg concentrate for solution for infusion

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 LEMTRADA

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.